|
1.
|
Coronel-Morán QR: Importancia del
laboratorio en el diagnóstico y pronóstico de leucemia aguda
linfoblástica de la infancia. Acta Pediátrica de México.
26:129–136. 2005.
|
|
2.
|
Mejia-Arangure JM, Bonilla M, Lorenzana R,
et al: Incidence of leukemias in children from El Salvador and
Mexico City between 1996 and 2000: population-based data. BMC
Cancer. 5:332005. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Salud/INEGI, S.d., Fuente: base de datos
de defunciones INEGI/Secretaria de Salud, Dirección General de
Información en Salud, México. Información disponible en URL
https://www.inegi.org.mx/ (Accessed
April, 2008).
|
|
4.
|
Cheok MH and Evans WE: Acute lymphoblastic
leukaemia: a model for the pharmacogenomics of cancer therapy. Nat
Rev Cancer. 6:117–129. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Hider SL, Bruce IN and Thomson W: The
pharmacogenetics of methotrexate. Rheumatology (Oxford).
46:1520–1524. 2007. View Article : Google Scholar
|
|
6.
|
Wang L, Goodey NM, Benkovic SJ and Kohen
A: Coordinated effects of distal mutations on environmentally
coupled tunneling in dihydrofolate reductase. Proc Natl Acad Sci
USA. 103:15753–15758. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Volpato JP, Fossati E and Pelletier JN:
Increasing methotrexate resistance by combination of active-site
mutations in human dihydrofolate reductase. J Mol Biol.
373:599–611. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Allemann RK, Evans RM, Tey LH, et al:
Protein motions during catalysis by dihydrofolate reductases.
Philos Trans R Soc Lond B Biol Sci. 361:1317–1321. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Fotoohi AK: Resistance of human leukaemia
cells to the antimetabolites. Oncology-Pathology, Suecia. 1:1–84.
2007.
|
|
10.
|
Serra M, Reverter-Branchat G, Maurici D,
et al: Analysis of dihydrofolate reductase and reduced folate
carrier gene status in relation to methotrexate resistance in
osteosarcoma cells. Ann Oncol. 5:151–160. 2004. View Article : Google Scholar
|
|
11.
|
De Jonge R, Hooijberg JH, van Zelst BD, et
al: Effect of polymorphisms in folate-related genes on in vitro
methotrexate sensitivity in pediatric acute lymphoblastic leukemia.
Blood. 106:717–720. 2005.PubMed/NCBI
|
|
12.
|
Assaraf YG: Molecular basis of antifolate
resistance. Cancer Metastasis Rev. 26:153–181. 2007. View Article : Google Scholar
|
|
13.
|
Goto Y, Yue L, Yokoi A, et al: A novel
single-nucleotide polymorphism in the 3′-untranslated region of the
human dihydrofolate reductase gene with enhanced expression. Clin
Cancer Res. 7:1952–1956. 2001.
|
|
14.
|
Dulucq S, St-Onge G, Gagne V, et al: DNA
variants in the dihydrofolate reductase gene and outcome in
childhood ALL. Blood. 111:3692–3700. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Seguro-popular: Secretaria de Salud/Seguro
Popular, Información disponible en URL http://www.seguro-popular.salud.gob.mx/uri
(Accessed May, 2009).
|
|
16.
|
Reiter A, Schrappe M, Ludwig WD, et al:
Chemotherapy in 998 unselected childhood acute lymphoblastic
leukemia patients. Results and conclusions of the multicenter trial
ALL-BFM 86. Blood. 84:3122–3133. 1994.PubMed/NCBI
|
|
17.
|
Smith M, Arthur D, Camitta B, et al:
Uniform approach to risk classification and treatment assignment
for children with acute lymphoblastic leukemia. J Clin Oncol.
14:18–24. 1996.PubMed/NCBI
|
|
18.
|
Merante F, Raha S, Reed JK and Proteau G:
The simultaneous isolation of RNA and DNA from tissues and cultured
cells. Methods Mol Biol. 58:3–9. 1996.PubMed/NCBI
|
|
19.
|
Organista-Nava J, Gómez-Gómez Y,
Saavedra-Herrera MV, et al: Polymorphisms of the γ-glutamyl
hydrolase gene and risk of relapse to acute lymphoblastic leukemia
in Mexico. Leukemia Res. 34:728–732. 2010.
|
|
20.
|
Kooloos WM, Wessels JAM, van der Straaten
T, Allaart CF, Huizinga TWJ and Guchelaar HJ: Functional
polymorphisms and methotrexate treatment outcome in recent-onset
rheumatoid arthritis. Pharmacogenomics. 11:163–175. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Gellekink H, Blom HJ, van der Linden IJ
and den Heijer M: Molecular genetic analysis of the human
dihydrofolate reductase gene: relation with plasma total
homocysteine, serum and red blood cell folate levels. Eur J Hum
Genet. 15:103–109. 2007. View Article : Google Scholar
|
|
22.
|
Mishra PJ, Longo GSA, Menon LG, Abali EE,
Humeniuk R, Cole PD, Kamen BA, Banerjee D and Bertino JR: The
829C-T single nucleotide polymorphism in the 30 UTR of the
dihydrofolate reductase gene results in methotrexate resistance and
is rare among non-Japanese American patients. Proc Amer Assoc
Cancer Res. 301:12742006.
|
|
23.
|
Parle-McDermott A, Pangilinan F, Mills JL,
et al: The 19-bp deletion polymorphism in intron-1 of dihydrofolate
reductase (DHFR) may decrease rather than increase risk for spina
bifida in the Irish population. Am J Med Genet Part A.
143:1174–1180. 2007. View Article : Google Scholar
|
|
24.
|
Ng SM, Lin HP, Ariffin WA, Zainab AK, Lam
SK and Chan LL: Age, sex, haemoglobin level, and white cell count
at diagnosis are important prognostic factors in children with
acute lymphoblastic leukemia treated with BFM-type protocol. J Trop
Pediatr. 46:338–343. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Frankel LS, Ochs J, Shuster JJ, et al:
Therapeutic trial for infant acute lymphoblastic leukemia: the
Pediatric Oncology Group experience (POG 8493). J Pediatr Hematol
Oncol. 19:351997. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Shuster JJ, Wacker P, Pullen J, et al:
Prognostic significance of sex in childhood B-precursor acute
lymphoblastic leukemia: a Pediatric Oncology Group Study. J Clin
Oncol. 16:2854–2863. 1998.PubMed/NCBI
|
|
27.
|
Kim K, Kang SB, Chung HH, Kim JW, Park NH
and Song YS: XRCC1 Arginine 194 Tryptophan and GGH-401
Cytosine/Thymine polymorphisms are associated with response to
platinum-based neoadjuvant chemotherapy in cervical cancer. Gynecol
Oncol. 111:509–515. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Dervieux T, Greenstein N and Kremer J:
Pharmacogenomic and metabolic biomarkers in the folate pathway and
their association with methotrexate effects during dosage
escalation in rheumatoid arthritis. Arthritis Rheum. 54:3095–3103.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Chessells JM, Veys P, Kempski H, et al:
Long term follow up of relapsed childhood acute lymphoblastic
leukaemia. Br J Haematol. 123:396–405. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Chen SH, Yang CP, Hung IJ, Jaing TH, Shih
LY and Tsai MH: Clinical features, molecular diagnosis, and
treatment outcome of infants with leukemia in Taiwan. Pediatr Blood
Cancer. 55:1264–1271. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Daniel-Cravioto A, Gonzalez-Bonilla CR,
Mejia-Arangure JM, et al: Genetic rearrangement MLL/AF4 is most
frequent in children with acute lymphoblastic leukemias in Mexico
City. Leuk Lymphoma. 50:1352–1360. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Bernaldez-Rios R, Ortega-Alvarez MC,
Perez-Saldivar ML, Alatoma-Medina NE and del Campo-Martinez M: The
age incidence of childhood B-cell precursor acute lymphoblastic
leukemia in Mexico City. J Pediatr Hematol/Oncol. 30:199–203. 2008.
View Article : Google Scholar : PubMed/NCBI
|
